Scientists have identified a type of immune cell in the lungs of humans that may help fight respiratory syncytial virus (RSV). The virus is one of the main causes of childhood hospitalisation, severe lung infection in...
An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common—and sometimes very serious—childhood disease. The findings, by...